investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Alan Rein

Retrovirus Assembly and Maturation

Leukaemia

Pathology Hematology and hematologic malignancies

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Pathology Hematology and hematologic malignancies

Alan Rein

Retrovirus Assembly and Maturation – Rockville

Leukaemia

Pathology Hematology and hematologic malignancies

Ann Mullally

Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells

Leukaemia

James Y. Chen

Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating

Leukaemia

Alexander Wlodawer

Protein Structure

Leukaemia

Anthony G Letai

Probing mitochondria and personalizing leukemia therapy with BH3 profiling

Leukaemia

Michael Clarke

Self-renewal of Normal and Leukemic Stem Cells

Leukaemia

Paul M Thompson

ENIGMA Center for Worldwide Medicine, Imaging & Genomics

Leukaemia